maribavir, Maribavir, LIVTENCITY 200 mg film-coated tablets., Maribavir
TAK-620-2004
Phase 3 small_molecule active
Quick answer
maribavir, Maribavir, LIVTENCITY 200 mg film-coated tablets., Maribavir for Cytomegalovirus (CMV) infection in children and adolescents who have received a hematopoietic stem cell transplant (HSCT) or a solid organ transplant (SOT) is a Phase 3 program (small_molecule) at Takeda Pharmaceuticals International AG with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Takeda Pharmaceuticals International AG
- Indication
- Cytomegalovirus (CMV) infection in children and adolescents who have received a hematopoietic stem cell transplant (HSCT) or a solid organ transplant (SOT)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active